2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Harvey I. Pass, MD, from the NYU Langone Medical Center, discusses the challenges of treating patients with mesothelioma.
Harvey I. Pass, MD, Stephen E. Banner Professor of Thoracic Oncology, Vice-Chair Research, Department of Cardiothoracic Surgery, Division Chief, General Thoracic Surgery, NYU Langone Medical Center, discusses the challenges of treating patients with mesothelioma.
Mesothelioma is a notorious disease of elderly people, Pass says, and symptoms may go unnoticed or develop slowly. Additionally, a delay in treatment could arise. Pass says that only about 20% of patients with mesothelioma are seen that may be good surgical candidates for a multimodality treatment.
It remains important to find the disease earlier, when effective treatment may have a chance.